Clinical Trial Update: Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating a vaccine to prevent recurrence in HER2-positive breast cancer, with the study currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HER2-positive breast cancer vaccine (trial)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer Female, Breast Cancer, Male | Phase 2 | Status: ACTIVE_NOT_RECRUITING